An Association of Users Has Already Been Established to Defend Generic Medicines
2 Articles
2 Articles
The decline in the share of generic medicines to 50.5% in April and the rise in costs caused by international instability threaten the sustainability of these drugs, today alerted the association of the sector, defending measures to safeguard supply.
UMG understands that generic medicines are subject to criteria of quality, safety and efficacy identical to those of brand name. The difference in price of brand name medicines does not reflect clinical superiority, but rather commercial, judicial strategies and rooted habits that persist in the circuit of prescription, defends.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium


